Cargando…

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia

Antigen-specific immunotherapies, in particular peptide vaccines, depend on the recognition of naturally presented antigens derived from mutated and unmutated gene products on human leukocyte antigens, and represent a promising low-side-effect concept for cancer treatment. So far, the broad applicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nelde, Annika, Maringer, Yacine, Bilich, Tatjana, Salih, Helmut R., Roerden, Malte, Heitmann, Jonas S., Marcu, Ana, Bauer, Jens, Neidert, Marian C., Denzlinger, Claudio, Illerhaus, Gerald, Aulitzky, Walter Erich, Rammensee, Hans-Georg, Walz, Juliane S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297687/ https://www.ncbi.nlm.nih.gov/pubmed/34305947 http://dx.doi.org/10.3389/fimmu.2021.705974

Ejemplares similares

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
por: Marconato, Maddalena, et al.
Publicado: (2022)

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
por: Tegeler, Christian M., et al.
Publicado: (2022)

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
por: Bilich, Tatjana, et al.
Publicado: (2020)

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
por: Bilich, Tatjana, et al.
Publicado: (2021)

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
por: Wacker, Marcel, et al.
Publicado: (2023)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
por: Roerden, Malte, et al.
Publicado: (2020)

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
por: Nelde, Annika, et al.
Publicado: (2022)

TOF(IMS) mass spectrometry-based immunopeptidomics refines tumor antigen identification
por: Hoenisch Gravel, Naomi, et al.
Publicado: (2023)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
por: Hackenbruch, Christopher, et al.
Publicado: (2023)

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
por: Heitmann, Jonas S., et al.
Publicado: (2021)

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
por: Tegeler, Christian M., et al.
Publicado: (2022)

The immunopeptidomic landscape of ovarian carcinomas
por: Schuster, Heiko, et al.
Publicado: (2017)

The Peptide Vaccine of the Future
por: Nelde, Annika, et al.
Publicado: (2021)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Kubiniok, Peter, et al.
Publicado: (2022)

SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function
por: Brunk, Fabian, et al.
Publicado: (2021)

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
por: Maringer, Yacine, et al.
Publicado: (2022)

Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
por: Seller, Anna, et al.
Publicado: (2023)

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
por: Bauer, Jens, et al.
Publicado: (2022)

Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
por: Marcu, Ana, et al.
Publicado: (2021)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

The Impact of Biomaterial Cell Contact on the Immunopeptidome
por: Ghosh, Michael, et al.
Publicado: (2020)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy
por: Roerden, Malte, et al.
Publicado: (2021)

BioWarehouse: a bioinformatics database warehouse toolkit
por: Lee, Thomas J, et al.
Publicado: (2006)

Are There Indeed Spliced Peptides in the Immunopeptidome?
por: Admon, Arie
Publicado: (2021)

Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data
por: ElAbd, Hesham, et al.
Publicado: (2021)

A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens
por: Backert, Linus, et al.
Publicado: (2017)

Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma
por: Heitmann, Jonas S, et al.
Publicado: (2020)

Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
por: Nelde, Annika, et al.
Publicado: (2022)

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2021)

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2020)

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models
por: Lübke, Maren, et al.
Publicado: (2019)

Building the data warehouse /
por: Inmon, William H.
Publicado: (1996)

Building the data warehouse
por: Inmon, W.H
Publicado: (2002)

Building the data warehouse
por: Inmon, William H
Publicado: (2005)

Automation in Warehouse Development
por: Hamberg, Roelof, et al.
Publicado: (2012)

Data Warehouse Designs
por: Silvers, Fon
Publicado: (2011)

Commentary: Are There Indeed Spliced Peptides in the Immunopeptidome?
por: Mishto, Michele
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l485k35ctrug1vns1340pe824u